Spinal Muscular Atrophy
PharmaShots Interview: Biogen’s Toby Ferguson Shares Insights on the use of Spinraza for the Treatment of Spinal Muscular Atrophy
May 10, 2022
Biogen to Initiate P-IIIb ASCEND Study Evaluating Higher Doses of Spinraza (nusinersen) for the Treatment of Spinal Muscular Atrop...
September 16, 2021
Chugai's Evrysdi (risdiplam) Receives MHLW's Approval for the Treatment of Spinal Muscular Atrophy
June 24, 2021
Roche Reports New Interim Data of JEWELFISH & RAINBOWFISH Studies for Evrysdi (risdiplam) to Treat Spinal Muscular Atrophy
June 11, 2021
Roche's Evrysdi (risdiplam) Receives Health Canada's Approval for Spinal Muscular Atrophy in Adults and Children
April 16, 2021
Roche and PTC's Evrysdi (risdiplam) Receive the EC's Approval as First and Only at Home Treatment For Spinal Muscular Atrophy
March 30, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.